|

Landiolol Clinical Trials

3 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 3: 1Phase 4: 2

Top Sponsors

  • Università Vita-Salute San Raffaele1
  • Insel Gruppe AG, University Hospital Bern1
  • Centre Hospitalier Universitaire, Amiens1

Indications

  • Heart Disease3
  • Beta-blocker2
  • Perioperative Myocardial Injury1
  • Low Cardiac Output Syndrome1
  • Myocardial Injury After Non-Cardiac Surgery1

Other3 trials

Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility
Phase 3
LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery
Phase 4
Landiolol in Mitral Valve Surgery
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.